This two-day, interactive short course focuses on the childhood management of myopia, and is designed for optometrists seeking to further their expertise in this practice area.
The topic areas to be covered in the course include:
- Myopia global picture (epidemiology, public health implications, etc.)
- Ocular complications of myopia
- An evidence-based approach to myopia diagnosis and management
- The landscape of myopia practice in Australia
- Discussing childhood myopia management with adult caregivers
- In-depth consideration of clinical evidence for myopia management including interventions, such as spectacles, contact lenses, pharmaceutical agents
- Myopia clinical case studies
- Orthokeratology practice (e.g., fundamentals of ortho-k, corneal topography, patient selection, ortho-k lens fitting, day 1 examination, review/aftercare).
On successful completion you will receive:
- 36 Continuing Professional Development (CPD) points (with 18 of these therapeutic points)
- A certificate of course completion.
Myopia is a potentially sight-threatening condition with increasing global prevalence. In the year 2000, about 23 percent of the world's population were myopic and 2.7 percent had high myopia. It has been predicted that by 2050, these statistics will rise to 49.8 percent and 9.8 percent respectively (Holden et al., 2015).
There is an evolving evidence base relating to interventions that have the potential to slow down the rate of myopia progression during childhood. This ‘Myopia Management Masterclass' will provide practical insight into contemporary myopia management for optometrists, by integrating clinical cases with the research literature. The course will provide clinicians with the skills necessary to navigate through the scientific literature, as relevant to myopia, and provide attendees with practical take-home messages to integrate within their own clinical practice.
There are no upcoming dates for this course.
Want to know about future sessions?
Register your details and we will email you about future intakes.